Latest news
Sarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer - simplywall.stsimplywall.st · Sat, 08 Aug 2026 10:47:29 GMTSarepta Therapeutics (SRPT) Names Michael Severino CEO Amid Gene Therapy Turbulence And Revenue Pressure - londoninsider.co.uklondoninsider.co.uk · Thu, 06 Aug 2026 19:31:19 GMTSarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:15:32 GMTSarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments - FinancialContentFinancialContent · Wed, 05 Aug 2026 20:05:00 GMTLegend CEO departs without successor in place—Chutes & Ladders - Fierce BiotechFierce Biotech · Fri, 31 Jul 2026 12:29:45 GMTPeople on the Move: Michael Severino, M.D., Joins Sarepta Therapeutics as Chief Executive Officer - BioBuzzBioBuzz · Thu, 30 Jul 2026 21:27:46 GMTSarepta Therapeutics, Inc. (SRPT) CEO gets 2,224,342 options, 756,104 RSUs - Stock TitanStock Titan · Thu, 30 Jul 2026 00:23:15 GMTSarepta Therapeutics Appoints Michael Severino as CEO - The Globe and MailThe Globe and Mail · Tue, 28 Jul 2026 13:38:00 GMT